BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Fuji
Cerilliant
McKinsey
Chubb
Cipla
Julphar
Citi
Cantor Fitzgerald
Mallinckrodt

Generated: January 18, 2018

DrugPatentWatch Database Preview

Flurazepam hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for flurazepam hydrochloride and what is the scope of flurazepam hydrochloride freedom to operate?

Flurazepam hydrochloride
is the generic ingredient in two branded drugs marketed by Valeant Pharm Intl, Aurolife Pharma Llc, Halsey, Hikma Intl Pharms, Hikma Pharms, Mylan Pharms Inc, Par Pharm, Purepac Pharm, Sun Pharm Industries, Superpharm, Usl Pharma, Warner Chilcott, and Watson Labs, and is included in twenty-three NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for flurazepam hydrochloride. Eight suppliers are listed for this compound.
Pharmacology for flurazepam hydrochloride
Ingredient-typeBenzodiazepines
Drug ClassBenzodiazepine
Medical Subject Heading (MeSH) Categories for flurazepam hydrochloride

US Patents and Regulatory Information for flurazepam hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs FLURAZEPAM HYDROCHLORIDE flurazepam hydrochloride CAPSULE;ORAL 072368-001 Mar 30, 1989 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs FLURAZEPAM HYDROCHLORIDE flurazepam hydrochloride CAPSULE;ORAL 071068-001 Nov 25, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Purepac Pharm FLURAZEPAM HYDROCHLORIDE flurazepam hydrochloride CAPSULE;ORAL 071927-001 Sep 9, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Usl Pharma FLURAZEPAM HYDROCHLORIDE flurazepam hydrochloride CAPSULE;ORAL 070562-001 Jul 9, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Purepac Pharm FLURAZEPAM HYDROCHLORIDE flurazepam hydrochloride CAPSULE;ORAL 071551-001 Sep 9, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Aurolife Pharma Llc FLURAZEPAM HYDROCHLORIDE flurazepam hydrochloride CAPSULE;ORAL 071717-002 Jul 31, 1991 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Superpharm FLURAZEPAM HYDROCHLORIDE flurazepam hydrochloride CAPSULE;ORAL 071660-001 Aug 4, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Usl Pharma FLURAZEPAM HYDROCHLORIDE flurazepam hydrochloride CAPSULE;ORAL 070563-001 Jul 9, 1987 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Superpharm FLURAZEPAM HYDROCHLORIDE flurazepam hydrochloride CAPSULE;ORAL 071659-001 Aug 4, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs FLURAZEPAM HYDROCHLORIDE flurazepam hydrochloride CAPSULE;ORAL 072369-001 Mar 30, 1989 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for flurazepam hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Pharm Intl DALMANE flurazepam hydrochloride CAPSULE;ORAL 016721-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Valeant Pharm Intl DALMANE flurazepam hydrochloride CAPSULE;ORAL 016721-002 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Cipla
Teva
Express Scripts
Johnson and Johnson
Cerilliant
McKesson
Mallinckrodt
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot